Recently Viewed
Clear All

Aurinia Pharmaceuticals Inc (AUPH)

factsheet Factsheet
  • Market Capitalisation market-capitalisation-info $1,320 Mln
  • Price to Earnings Ratio price-to-earning --
  • 12 Month Earnings monthly-earning $-71 Mln

Aurinia Pharmaceuticals Inc (AUPH) Share Price

NASDAQ

$8.54

As on 27-Nov-2023 16:13 EST

up-down-arrow $-0.63 • -6.87%

  • Prev Close info

    $9.17

  • Day's Openinfo

    $9.15

  • Today's Highinfo

    $9.29

  • Today's Lowinfo

    $8.52

  • Today's Volumeinfo

    2,230,656

  • 52 Week rangeinfo

    $4.07 - 12.43

Aurinia Pharmaceuticals Inc (AUPH) Stock Performance
YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
Aurinia Pharmaceuticals (AUPH)
97.69 16.51 -7.97 75.00 -15.15 9.32 --
S&P BSE Sensex*
8.77 3.75 1.98 6.23 14.44 13.26 12.48
S&P Small-Cap 600#
-5.82 -5.34 -13.90 -6.30 5.30 2.98 5.53
As on 27-Nov-2023  |  *As on 28-Nov-2023  |  #As on 26-Oct-2023
2022
2021
2020
2019
2018
2017
2016
Aurinia Pharmaceuticals (AUPH)
-81.11 65.37 -31.74 197.07 50.22 115.71 -14.98
S&P Small-Cap 600
-17.42 25.27 9.57 20.86 -9.70 11.73 24.74
S&P BSE Sensex
4.44 21.99 15.75 14.38 5.87 27.91 1.95

Valuation
Stock
Peer Median

Growth & Efficiency
Stock
Peer Median

Solvency

Is there a threat to this company's solvency in the future?

Financial Manipulation

Can creative accounting be detected through the financial numbers?

More Details about Key Ratiosarrow

Aurinia Pharmaceuticals Inc (AUPH) Peer Comparison

search
search
search
search
    See More Peer Comparisonsarrow

    Valuation Chart of Aurinia Pharmaceuticals Inc (AUPH)

        Financials

        See More Financial Detailsarrow

        Shareholding Pattern

        See More Details of Holdingsarrow

        Other details of Aurinia Pharmaceuticals Inc (AUPH)

        Pres, CEO & Director

        Mr. Peter S. Greenleaf M.B.A.

        Chief Financial Officer

        Mr. Joseph M. Miller CPA

        Headquarters

        Victoria, BC

        Website

        https://www.auriniapharma.com
        More Detailsarrow

        FAQs for Aurinia Pharmaceuticals Inc (AUPH)

        The total asset value of Aurinia Pharmaceuticals Inc (AUPH) stood at $ 494 Mln as on 31-Mar-23

        The share price of Aurinia Pharmaceuticals Inc (AUPH) is $8.54 (NASDAQ) as of 27-Nov-2023 16:13 EST. Aurinia Pharmaceuticals Inc (AUPH) has given a return of -15.15% in the last 3 years.

        Aurinia Pharmaceuticals Inc (AUPH) has a market capitalisation of $ 1,320 Mln as on 23-Jun-2023. As per Value Research classification, it is a Small Cap company.

        The P/B ratio of Aurinia Pharmaceuticals Inc (AUPH) is 1.57 times as on 23-Jun-2023, a -0.38% premium to its peers’ median range of 2.54 times.

        Since, TTM earnings of Aurinia Pharmaceuticals Inc (AUPH) is negative, P/E ratio is not available.

        Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
        Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
        Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
        Step 4. Search for the Aurinia Pharmaceuticals Inc (AUPH) and enter the required number of quantities and click on buy to purchase the shares of Aurinia Pharmaceuticals Inc (AUPH).

        Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States. The company also offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. Aurinia Pharmaceuticals Inc. is headquartered in Victoria, Canada.

        The CEO & director of Mr. Peter S. Greenleaf M.B.A.. is Aurinia Pharmaceuticals Inc (AUPH), and CFO & Sr. VP is Mr. Joseph M. Miller CPA.

        The promoters of Aurinia Pharmaceuticals Inc (AUPH) have pledged 0% of the total equity as on Mar-23.

        Some of the close peers are:

        Company Market Cap($ Mln)
        Mirum Pharmaceuticals (MIRM)
        104
        MannKind Corp (MNKD)
        104
        Innoviva (INVA)
        83
        Lyell Immunopharma Inc (LYEL)
        81
        Aurinia Pharmaceuticals Inc (AUPH) Ratios
        Return on equity(%)
        -23.78
        Return on capital employed(%)
        --
        Debt-to-equity ratio
        0
        Dividend yield(%)
        0

        No, TTM profit after tax of Aurinia Pharmaceuticals Inc (AUPH) was $-71 Mln.

        Stock Screeners

        Select stocks based on pre-defined filters or customised as per your needs.
        stocks-selector-icon

        Market Monitor

        Returns of all major Indian and Global equity indices across time periods.
        indices-icon

        Who Owns What?

        Search a company by name to view which funds hold its shares.
        who-owns-what-icon

        My Investments

        Elevate your portfolio with detailed analytics, powerful tools and handpicked recommendations. See how all your investments are performing.
        my_investment

        My Watchlist

        Keep an eye on the investments you wish to invest in
        watchlist_icon

        SIP Calculator

        Calculate how much you can accumulate with your monthly savings.
        wealth-selector-icon
        See All Tools right-arrow
        Edit peer-selector-edit

        Key Facts

        • Market cap market-cap-information $1,320.20 Mln
        • Revenue (TTM)revenue-information $146.81 Mln
        • Earnings (TTM) earning-information $-70.71 Mln
        • Cash date-information $361.53 Mln
        • Total Debt info $7.93 Mln
        • Insider's Holding 7.07%
        • Liquidity liquidity High
        • 52 Week range week-range $4.07 - 12.43
        • Shares outstanding share-outstanding 143,034,000
        • 10 Years Aggregate:

          CFO: $-521.22 Mln

          EBITDA: $-655.54 Mln

          Net Profit: $-711.68 Mln

        About The Company

        • IPO Date 26-Jan-1999
        • Pres, CEO & Director Mr. Peter S. Greenleaf M.B.A.
        • Chief Financial Officer Mr. Joseph M. Miller CPA
        • Listing key-listing NASDAQ: AUPH
        • Country Canada
        • Headquarters headquarters Victoria, BC
        • Website website https://www.auriniapharma.com
        • Business

          Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States. The company also offers LUPKYNIS for the treatment...  of adult patients with active lupus nephritis. It has a collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. Aurinia Pharmaceuticals Inc. is headquartered in Victoria, Canada.  Read more

        Demystifying Stocks.

        At Value Research, we believe it's best to understand investments before diving in. And since 1990, we've been doing exactly that – helping & guiding lakhs of Indians with their investing journey. Join the journey.

        Sign Up for Free
        demystifying-mutual-fund

        What can Value Research do for you?

        solidify-your-fundamentals
        Solidify your fundamentals

        Learn the principles, mindset and tools you need to become a successful Mutual Fund and Stock investor from the masters who have been doing this for decades.

        track-all-your-investments
        Track all your investments

        Use India's most advanced investment tracker to track, analyse and get updates and insights on your investments.

        get-guidance-from-our-experts
        Get guidance from our experts

        Get an analysis of your portfolio along with actionable, general tips and insights, guidance on where to invest based on your goals, and experts' opinions on individual Mutual Funds and Stocks.

        get-access-to-exclusive-analytics
        Get access to exclusive analytics

        Value Research offers the most advanced and detailed data & analytics available on Mutual Funds and Stocks. Sign up and unlock the power yourself.

        Explore All Features page-redirect-arrow

        Explore it yourself, for free

        Sign up and get access to:

        Unlimited access to advice from India's top experts

        The most comprehensive analysis of funds and stocks in India

        A holistic portfolio manager to help track all your investments easily

        And much more, like guides, tools, webinars, videos and eBooks.

        Sign Up for Free
        share-fund-plan-icon